EP0714663A3
(en)
*
|
1994-11-28 |
1997-01-15 |
Lilly Co Eli |
Potentiation of drug responses by serotonin 1A receptor antagonists
|
CN1195287A
(zh)
*
|
1995-07-24 |
1998-10-07 |
伊莱利利公司 |
注意力涣散/多动症的治疗
|
DE69607904T2
(de)
*
|
1995-08-16 |
2000-10-05 |
Lilly Co Eli |
Potenzierung von Serotonin-Wirkstoffresponz
|
US6075040A
(en)
|
1996-09-05 |
2000-06-13 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
ZA967892B
(en)
*
|
1995-09-21 |
1998-03-18 |
Lilly Co Eli |
Selective β3 adrenergic agonists.
|
EP0792649A1
(en)
*
|
1996-02-29 |
1997-09-03 |
Eli Lilly And Company |
Treatment of sleep disorders
|
FR2746314B1
(fr)
*
|
1996-03-25 |
1998-06-12 |
Pf Medicament |
Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee
|
US20060062843A1
(en)
*
|
1996-03-25 |
2006-03-23 |
Wyeth |
Extended release formulation
|
US6274171B1
(en)
|
1996-03-25 |
2001-08-14 |
American Home Products Corporation |
Extended release formulation of venlafaxine hydrochloride
|
US20030215507A1
(en)
*
|
1996-03-25 |
2003-11-20 |
Wyeth |
Extended release formulation
|
EP0818198A1
(en)
*
|
1996-07-09 |
1998-01-14 |
Lilly S.A. |
Potentiation of drug response by increasing serotonin availability
|
US5958429A
(en)
*
|
1996-08-16 |
1999-09-28 |
Eli Lilly And Company |
Potentiation of serotonin response
|
US5958965A
(en)
*
|
1996-08-27 |
1999-09-28 |
American Home Products Corporation |
4-aminoethoxy indoles
|
FR2752732B1
(fr)
*
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
ATE215369T1
(de)
|
1996-09-05 |
2002-04-15 |
Lilly Co Eli |
Carbazolanaloge als selektive beta3-adrenergische agonisten
|
US6087376A
(en)
*
|
1997-02-05 |
2000-07-11 |
University Of Kentucky Research Foundation |
Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
|
US5830904A
(en)
*
|
1997-02-05 |
1998-11-03 |
University Of Kentucky Research Foundation |
Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
|
FR2759290B1
(fr)
*
|
1997-02-13 |
2004-06-18 |
Pf Medicament |
Minalcipran pour le traitement de l'incontinence urinaire
|
FR2759906B1
(fr)
*
|
1997-02-21 |
2004-06-04 |
Pf Medicament |
Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
|
US5776969A
(en)
*
|
1997-02-27 |
1998-07-07 |
Eli Lilly And Company |
Treatment of sleep disorders
|
US5910319A
(en)
*
|
1997-05-29 |
1999-06-08 |
Eli Lilly And Company |
Fluoxetine enteric pellets and methods for their preparation and use
|
GB9714675D0
(en)
*
|
1997-07-11 |
1997-09-17 |
Smithkline Beecham Plc |
Novel composition
|
NZ502252A
(en)
*
|
1997-07-25 |
2001-09-28 |
H |
Indole and 2,3-dihydroindole derivatives useful for inhibiting serotonin reuptake and antagonism of 5-HT1a receptors
|
UA56257C2
(uk)
*
|
1997-09-23 |
2003-05-15 |
Елі Ліллі Енд Компані |
Спосіб лікування неадекватної визивної поведінки
|
WO1999015177A1
(en)
*
|
1997-09-23 |
1999-04-01 |
Eli Lilly And Company |
Treatment of attention-deficit/hyperactivity disorder
|
UA57107C2
(uk)
*
|
1997-09-23 |
2003-06-16 |
Елі Ліллі Енд Компані |
Спосіб лікування розладу поведінки
|
JP2001520195A
(ja)
*
|
1997-10-17 |
2001-10-30 |
イーライ・リリー・アンド・カンパニー |
医薬の増強
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
US6037360A
(en)
*
|
1997-10-28 |
2000-03-14 |
Vivus, Incorporated |
Administration of 5-HT3 receptor antagonists to treat premature ejaculation
|
CO5011072A1
(es)
*
|
1997-12-05 |
2001-02-28 |
Lilly Co Eli |
Etanolaminas pirazinil substituidas como agfonistas de los receptores
|
US20030013740A1
(en)
*
|
1998-03-27 |
2003-01-16 |
Martin P. Redmon |
Stable dosage forms of fluoxetine and its enantiomers
|
US6500827B2
(en)
*
|
1998-05-08 |
2002-12-31 |
Pharmacia & Upjohn Company |
Drug combinations
|
WO1999058130A1
(en)
*
|
1998-05-08 |
1999-11-18 |
Pharmacia & Upjohn Company |
New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol
|
AU4100699A
(en)
*
|
1998-05-28 |
1999-12-13 |
Sepracor, Inc. |
Compositions and methods employing r(-) fluoxetine and other active ingredients
|
FR2781671A1
(fr)
*
|
1998-07-28 |
2000-02-04 |
Synthelabo |
Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique
|
US6974838B2
(en)
*
|
1998-08-24 |
2005-12-13 |
Sepracor Inc. |
Methods of treating or preventing pain using sibutramine metabolites
|
US6476078B2
(en)
*
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
US6331571B1
(en)
|
1998-08-24 |
2001-12-18 |
Sepracor, Inc. |
Methods of treating and preventing attention deficit disorders
|
US6339106B1
(en)
|
1999-08-11 |
2002-01-15 |
Sepracor, Inc. |
Methods and compositions for the treatment and prevention of sexual dysfunction
|
AU746887B2
(en)
*
|
1998-09-15 |
2002-05-02 |
Eli Lilly And Company |
Treatment of persistent pain
|
US6465458B1
(en)
*
|
1999-07-01 |
2002-10-15 |
Pharmacia & Upjohn Company |
Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
|
US6399826B1
(en)
|
1999-08-11 |
2002-06-04 |
Sepracor Inc. |
Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
|
NZ517038A
(en)
|
1999-09-03 |
2003-04-29 |
Lilly Co Eli |
Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
|
CN1414953A
(zh)
*
|
1999-11-03 |
2003-04-30 |
阿尔巴尼分子研究公司 |
芳基和杂芳基取代的四氢异喹啉及其阻断去甲肾上腺素、多巴胺和5-羟色胺重摄取的用途
|
US7163949B1
(en)
|
1999-11-03 |
2007-01-16 |
Amr Technology, Inc. |
4-phenyl substituted tetrahydroisoquinolines and use thereof
|
UA77650C2
(en)
*
|
1999-12-06 |
2007-01-15 |
Lundbeck & Co As H |
Use of serotonin reuptake inhibitor in combination with deramcyclane
|
GB0004003D0
(en)
*
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
MXPA02008659A
(es)
*
|
2000-03-07 |
2003-02-24 |
Lilly Co Eli |
Tratamiento de la psoriasis.
|
GB2362826A
(en)
*
|
2000-06-02 |
2001-12-05 |
Lilly Co Eli |
A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
|
AU7334901A
(en)
*
|
2000-07-11 |
2002-01-21 |
Du Pont Pharm Co |
Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
|
DE10042412B4
(de)
*
|
2000-08-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
|
US20040030131A1
(en)
*
|
2000-10-04 |
2004-02-12 |
Martine Keenan |
Pharmaceutical compounds
|
US20060287335A1
(en)
*
|
2000-11-28 |
2006-12-21 |
Wyeth |
Serotonergic agents for treating sexual dysfunction
|
US20060223824A1
(en)
|
2000-11-28 |
2006-10-05 |
Wyeth |
Serotonergic agents
|
FR2817257B1
(fr)
*
|
2000-11-30 |
2009-03-20 |
Sanofi Synthelabo |
Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
|
US6833377B2
(en)
|
2001-02-05 |
2004-12-21 |
Gevys Pharmaceuticals Ltd. |
Composition and method for potentiating drugs
|
US20050192220A1
(en)
*
|
2001-02-05 |
2005-09-01 |
Gevys Pharmaceuticas Ltd. |
Composition and method for potentiating drugs
|
US6855729B2
(en)
*
|
2001-02-20 |
2005-02-15 |
Timothy G. Dinan |
Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
|
US6610887B2
(en)
*
|
2001-04-13 |
2003-08-26 |
Sepracor Inc. |
Methods of preparing didesmethylsibutramine and other sibutramine derivatives
|
US7034059B2
(en)
|
2001-07-02 |
2006-04-25 |
Sepracor Inc. |
Methods of using norfluoxetine
|
US20030087963A1
(en)
|
2001-09-13 |
2003-05-08 |
Senanayake Chris H. |
Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
|
US20040034101A1
(en)
*
|
2001-11-05 |
2004-02-19 |
Cypress Bioscience, Inc. |
Treatment and prevention of depression secondary to pain (DSP)
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
CA2475763A1
(en)
*
|
2002-02-12 |
2003-08-21 |
Cypress Bioscience, Inc. |
Methods of treating attention deficit/hyperactivity disorder (adhd)
|
CA2382419A1
(en)
*
|
2002-04-24 |
2003-10-24 |
Le Groupe Lysac Inc. |
Synergistic blends of polysaccharides as biodegradable absorbent materials or superabsorbents
|
CN1671368A
(zh)
*
|
2002-07-24 |
2005-09-21 |
柏树生物科学公司 |
疼痛继发性抑郁(dsp)的治疗
|
US20040106681A1
(en)
*
|
2002-10-03 |
2004-06-03 |
Cypress Bioscience, Inc. |
Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
|
US7704527B2
(en)
*
|
2002-10-25 |
2010-04-27 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
ATE401872T1
(de)
*
|
2003-02-14 |
2008-08-15 |
Pf Medicament |
Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels
|
FR2851163B1
(fr)
*
|
2003-02-14 |
2007-04-27 |
|
Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
|
GB0309440D0
(en)
*
|
2003-04-25 |
2003-06-04 |
Lilly Co Eli |
Quinolone derivatives
|
US20040265372A1
(en)
*
|
2003-06-27 |
2004-12-30 |
David Wynn |
Soft tablet containing high molecular weight cellulosics
|
US20040265373A1
(en)
*
|
2003-06-27 |
2004-12-30 |
David Wynn |
Soft tablet containing high molecular weight cellulosics
|
AR047553A1
(es)
|
2003-07-04 |
2006-01-25 |
Lundbeck & Co As H |
La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
|
US20050226923A1
(en)
*
|
2004-04-07 |
2005-10-13 |
Gassert Chad M |
Venlafaxine compositions in the form of microtablets
|
MX2007000428A
(es)
|
2004-07-15 |
2008-03-05 |
Amr Technology Inc |
Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina.
|
US20060111385A1
(en)
*
|
2004-11-22 |
2006-05-25 |
Molino Bruce F |
Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
|
US20060111394A1
(en)
*
|
2004-11-22 |
2006-05-25 |
Molino Bruce F |
Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
|
US20060111393A1
(en)
*
|
2004-11-22 |
2006-05-25 |
Molino Bruce F |
4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
|
MX2007010524A
(es)
*
|
2005-03-01 |
2008-01-16 |
Wyeth Corp |
Formas cristalinas y amorfas del clorhidrato 4-ciano-n-{(2r)-2-[4- (2,3-dihidro-benzo[1-4]dioxin-5-il)-piperazin-1-il]-propil}-n- piridin-2-il-benzamida.
|
CA2615403C
(en)
*
|
2005-07-15 |
2015-06-16 |
Amr Technology, Inc. |
Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
BRPI0720958A2
(pt)
*
|
2006-12-27 |
2014-03-18 |
Lek Pharmaceuticals |
Omposição de duloxetina
|
AR071997A1
(es)
*
|
2008-06-04 |
2010-07-28 |
Bristol Myers Squibb Co |
Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
EP2429293B1
(en)
|
2009-05-12 |
2014-10-29 |
Bristol-Myers Squibb Company |
CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
|
KR20120034644A
(ko)
*
|
2009-05-12 |
2012-04-12 |
알바니 몰레큘라 리써치, 인크. |
아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
|
ES2662072T3
(es)
|
2009-05-12 |
2018-04-05 |
Albany Molecular Research, Inc. |
7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y uso de la misma
|
WO2011057176A1
(en)
*
|
2009-11-06 |
2011-05-12 |
Forest Laboratories Holding Limited |
Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
|
EP2606049A4
(en)
|
2010-08-17 |
2014-01-08 |
Albany Molecular Res Inc |
2,5-METHANO- AND 2,5-ETHANO-TETRAHYDROBENZAZEPINE DERIVATIVES AND USES THEREOF FOR BLOCKING NOREPINEPHRINE, DOPAMINE, AND SEROTONIN REUPTAKE
|
EP2959904A1
(en)
|
2014-06-27 |
2015-12-30 |
Institut De Recerca Contra La Leucemia Josep Carreras |
Methods for treating, diagnosing and prognosing a haematological malignancy
|
EP3348266A1
(en)
|
2017-01-16 |
2018-07-18 |
Leukos Biotech, S.L. |
Combination therapy for treating cancer
|